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Introduction
Piper porphyrophyllum of Piperaceae or locally known as Lada hutan, Sireh rimau, Kerakap rimau, and Akar bugu was reported to contain seven flavonoids identified as 5-hydroxy-7-methoxyflavanone (1), 5,7-dimethoxyflavone (2), 4 0 ,5,7-trimethoxyflavone (3), 3 0 ,4 0 ,5,7-tetramethoxyflavone (4), 4 0 -hydroxy-3 0 ,5,7-trimethoxyflavone (5), 5-hydroxy-3 0 ,4 0 ,7-trimethoxyflavone (6), and 4 0 ,5-dihydroxy-3 0 ,7-dimethoxyflavone (7) (Rajudin et al., 2010) .
Compounds 1-4 isolated from the hexane extract while 5-7 were obtained from the ethyl acetate extract.
Re-investigation of the ethyl acetate extract resulted in the isolation of cubebin (8) (Pascoli et al., 2006; Bastos et al., 2001 ) and 3,3 0 ,4 0 -trihydroxy-5,7-dimethoxyflavone (9) (Daniel et al., 1999) . Compound 9 is reported for the first time in genus Piper.
Herein we report the antimicrobial and anti-inflammatory activities of the extracts and isolated compounds.
The ethyl acetate extract showed potent antibacterial activity against S. aureus followed by compound (4) each with MIC values of 62.5 and 250 lg/mL, respectively. Compound (1) and (7) were active against the Gram-negative bacteria (P. aeruginosa) both with MIC = 125 lg/mL. As for the remaining compounds, they are moderate or weak inhibitors. The antibacterial activity against S. aureus, a major human pathogen, which can colonize many different diseases is significant (Schwarz-Linek et al., 2006) . The significant antibacterial activity exhibited by (2) and (7) against Gram-negative strain, P. aeruginosa showed that these compounds have the ability to penetrate the outer membrane of the bacteria which is a barrier to many substances, including antibiotics (Palombo and Semple, 2001) .
At a dose of 2 mg per ear, the hexane extract showed the highest inhibition in TPA-induced edema with IE 92.12 ± 9.1% while the ethyl acetate extract only reduced 64.13 ± 4.9% of the edema compared to indomethacin (the standard) which gave 85.50 ± 5.01% inhibition. At a dose of 0.5 mg per ear, (4) and (2) which were isolated from the hexane extract, exhibited significant activity by inducing 53.64 ± 5.0 and 50.13 ± 7.0% reduction in the edema, respectively. In contrast, the other compounds showed low activity (in the range of 27-24%) or inactive in this anti-inflammatory model. In the in vitro quantitative lipoxygenase inhibition assay, the hexane extract again displayed the highest inhibition (99.72 ± 0.02%) while the ethyl acetate extract was found to be inactive. 4 0 ,5-Dihydroxy-3 0 ,7-dimethoxyflavone (7) which was obtained from the ethyl acetate extract exhibited the highest inhibition with IE 91.81 ± 0.05%. Compound (1) gave moderate activity (53.31 ± 0.04) followed by (5) (48.1 ± 0.0%) and (8) (42.92 ± 0.05%) when compared to the standard, phenidone (89.39 ± 0.04%).
In the (12-O-tetradecanoylphorobol-13-acetate) TPAinduced edema, the active extracts and compounds were probably inhibited protein kinase C (PKC), the principle target of TPA, thus blocked the production of phospholipase A 2 . In the case of in vitro quantitative lipoxygenase assay, the active extract and compounds inhibited leukotriene synthesis on lipoxygenase pathway (Daniel et al., 1999) .
In this study, synergic effects of the isolated compounds might be the caused for the antimicrobial and anti-inflammatory activities of the ethyl acetate and hexane extracts, respectively. However, further study is necessary to assess the interaction of both extract and isolated compounds with other model of experiments, in order to verify their mechanisms of action. 
Experimental

Isolation and purification
The air dried and powdered sample (760.3 g) was extracted using Soxhlet extractor with hexane and ethyl acetate sequentially. Evaporation of the respective solvents gave hexane (2.64 g, 0.35%) and ethyl acetate (3.87 g, 0.51%) extracts. Fractionation and purification of the hexane extract by vacuum liquid chromatography and multiple column chromatography afforded four compounds (1-4) while purification of the ethyl acetate extract using the same methodology as the hexane gave five pure compounds (5-9). The structural elucidations of the compounds were based on the spectroscopic data and comparison of the spectral data with the literatures.
Microorganisms and medium
The bacterial stains were provided from the Biology Laboratory, Faculty of Bioscience and Bioengineering, UTM and acquired from The American Type Culture Collection (ATCC). The bacterial strains were S. aureus (ATCC 25923), P. aeruginosa (ATCC 27853) and Escherichia coli (ATCC 25922). The nutrient broth was suspended in distilled water and autoclaved for 20 min at 121°C. Each of the strains was suspended on nutrient broth in sterilized test tubes. The inocula were prepared by adjusting the turbidity of the suspension to match 0.5 McFarland standard in barium salts suspension. Streptomycin sulphate was used as the positive control.
Minimum inhibition concentration (MIC)
The MIC was determined by the micro-titer broth dilution method (Zavala et al., 1997) . The test was performed in sterile 96-well micro-titer plates. The methanolic solution of samples were properly prepared and transferred to each microplate well in order to obtain a twofold serial dilution of the original solution (1:2-1:128 starting from the concentration of 1000 lg/mL). The inoculate (100 lL) containing 150 · 106 colony/unit of each microorganism were added to each well. A number of wells were reserved for methanol effect. Plates were incubated at 37 ± 1°C for 24 h. MIC was defined as the lowest concentration that had no macroscopically visible growth.
Minimum bactericidal concentration (MBC)
The determination of MBC was according to the method by Arias et al. (2004) . All wells in the MIC study, which did not show any growth of bacteria after incubation were first diluted in fresh nutrient broth (1:4) and sub-cultured onto the surface of freshly prepared nutrient agar plates (h, 15 mm). The plates were incubated for 18 h at 37 ± 1°C. The MBC was recorded as the lowest concentration of the sample that did not permit any visible growth of bacteria colony on the agar plate after incubation period.
TPA-induced mouse ear edema model and in vitro quantitative lipoxygenase inhibition assay
Both experiments were carried following the previous methods reported (Rajudin et al., 2008) .
The results were expressed as mean ± standard deviation obtained from five mice in the TPA-mouse ear edema and from three samples in vitro quantitative lipoxygenase assay.
